|
|
 |
|
 |
 |
"Sanofi-aventis has one of the industry's leading oncology portfolios, which includes TaxotereŽ and EloxatinŽ, two of the most widely used chemotherapy agents worldwide. We are pleased to offer TaxotereŽ and EloxatinŽ to our membership."
- Joe Lewarski
- COO & Managing Partner, Oncology Associates |
 |
 |
|
|
 |
|
|
 |
 |
 |
|
 |
| Aventis Oncology is globally committed to addressing the tough challenges facing healthcare professionals and their patients. With cancer being a leading cause of death in the world today, innovative solutions in cancer care are critical. Aventis Oncology shares this sense of urgency. That's why Aventis strives for new solutions that will improve the lives of cancer patients. |
|
| Product Contracts Offered Through OA: |
|
|
|
|
 |
 |
|
